NCT00231283View on ClinicalTrials.gov

NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

July 31, 2005

Conditions

Coronary Artery Disease

Interventions

DEVICE

CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS)

CYPHER NxT Sirolimus-eluting Coronary Stent on the BX SONIC Over-the-wire Stent Delivery System

Trial Locations (1)

77030

Texas Heart Institute, Houston

Sponsors

Lead Sponsor

Cordis Corporation

All Listed Sponsors

lead

Cordis Corporation

INDUSTRY

NCT00231283 - NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions | Biotech Hunter | Biotech Hunter